EUVIMEDEUVIMED entdecken
Crossref

The effect of vortioxetine on faecal microbiota in high‐fat diet‐exposed mice—A link to weight protection

Henrik Thyge Corfitsen iD, Katrine Bilde, Trine Rerup, Agnete Larsen

Basic & Clinical Pharmacology & Toxicology · 2024

DOI: 10.1111/bcpt.14058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2024. Verfasst von Henrik Thyge Corfitsen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Aarhus University, Aarhus, Denmark. Hauptthemen laut MEDLINE: Vortioxetine, Diet, High-Fat, Feces, Mice, Inbred C57BL. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Axel Muusfeldt fonden, Region Midtjylland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Weight gain is a common side effect of antidepressive treatment, causing distress among patients and caretakers as it can lead to treatment discontinuation and complications such as diabetes type II and cardiovascular disease. Vortioxetine is one of the newer antidepressants and the pharmacodynamics differ from the selective serotonin reuptake inhibitors. It is marketed as being weight neutral; however, there is little evidence as to why. In recent years, there has been an increased focus on the faecal microbiota and its impact on body weight and mental and physical health. In the current work, we examine the effect of vortioxetine on weight gain and faecal microbiota composition.

Methods

Forty male C57BL/6NTac mice were primed for 8 weeks with a high‐fat diet (Hfd) or control diet (Cd), followed by a 4‐week period on the same diet and additional +/− vortioxetine 10 mg/kg/daily.

Results

Vortioxetine reduced Hfd‐induced weight gain (Hfd + V: 8.2%, Hfd − V: 12.7%; p = 0.0374) but did not affect weight gain of the control group (Cd + V: 7.54%, Cd − V: 7.56%; p = 0.4944). Significant differences in faecal microbiota were observed in mice who received vortioxetine.

Conclusion

Vortioxetine caused significant changes to the faecal microbiota composition and appeared to limit Hfd‐induced weight gain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VortioxetineDiet, High-FatFecesMice, Inbred C57BLWeight GainGastrointestinal MicrobiomeAnimalsMaleMiceAntidepressive AgentsSelective Serotonin Reuptake InhibitorsObesityDisease Models, Animal

Stichwörter der Autor:innen

faecal microbiotamicevortioxetineweight gain

Substanzen

VortioxetineAntidepressive AgentsSelective Serotonin Reuptake Inhibitors

Autor:innen und Institutionen

  • Department of Biomedicine, Aarhus University, Aarhus, Denmark.

ORCID-Profile: Henrik Thyge Corfitsen

Förderung

  • Axel Muusfeldt fonden
  • Region Midtjylland

Zitieren

APA

Corfitsen, H. T., Bilde, K., Rerup, T., & Larsen, A. (2024). The effect of vortioxetine on faecal microbiota in high‐fat diet‐exposed mice—A link to weight protection. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.14058

Vancouver

Corfitsen HT, Bilde K, Rerup T, Larsen A. The effect of vortioxetine on faecal microbiota in high‐fat diet‐exposed mice—A link to weight protection. Basic & Clinical Pharmacology & Toxicology. 2024. doi:10.1111/bcpt.14058

BibTeX
@article{Corfitsen2024,
  author = {Corfitsen, Henrik Thyge and Bilde, Katrine and Rerup, Trine and Larsen, Agnete},
  title = {The effect of vortioxetine on faecal microbiota in high‐fat diet‐exposed mice—A link to weight protection},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2024},
  doi = {10.1111/bcpt.14058}
}
Kostenlos starten →